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Language impairment in a case of a
complex chromosomal rearrangement with
a breakpoint downstream of FOXP2
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Antonio Benítez-Burraco5,6, Dianne F. Newbury1 and Paloma García-Bellido2,5*
Abstract
Background: We report on a young female, who presents with a severe speech and language disorder and a
balanced de novo complex chromosomal rearrangement, likely to have resulted from a chromosome 7
pericentromeric inversion, followed by a chromosome 7 and 11 translocation.
Results: Using molecular cytogenetics, we mapped the four breakpoints to 7p21.1-15.3 (chromosome position:
20,954,043-21,001,537, hg19), 7q31 (chromosome position: 114,528,369-114,556,605, hg19), 7q21.3 (chromosome position:
93,884,065-93,933,453, hg19) and 11p12 (chromosome position: 38,601,145-38,621,572, hg19). These regions contain only
non-coding transcripts (ENSG00000232790 on 7p21.1 and TCONS_00013886, TCONS_00013887, TCONS_00014353,
TCONS_00013888 on 7q21) indicating that no coding sequences are directly disrupted. The breakpoint on 7q31 mapped
200 kb downstream of FOXP2, a well-known language gene. No splice site or non-synonymous coding variants were
found in the FOXP2 coding sequence. We were unable to detect any changes in the expression level of FOXP2 in
fibroblast cells derived from the proband, although this may be the result of the low expression level of FOXP2 in
these cells.
Conclusions: We conclude that the phenotype observed in this patient either arises from a subtle change in FOXP2
regulation due to the disruption of a downstream element controlling its expression, or from the direct disruption of
non-coding RNAs.
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Background
Developmental language disorders provide a window
into the biological underpinnings of language [1, 2]. The
characterization of clinical cases with genetic anomalies
that can be associated with (endo)phenotypes of lan-
guage is helping to unravel the genetic pathways under-
lying this human ability. One of these genes is FOXP2, a
transcription factor located in 7q31 [3]. A missense mu-
tation in FOXP2 was first identified in a family (KE) with
orofacial dyspraxia and language deficits affecting lexical
semantics, morphology, syntax, and phonology [4–7].
Broad cognitive deficits were also observed in affected
members [5, 6].
Subsequent studies have described different disrup-
tions of FOXP2. Balanced translocations involving 7q31
have been described, both directly affecting the coding
region of FOXP2 [8] or with breakpoints near the gene
[9]. They normally give rise to speech and language im-
pairments, possibly in the form of spastic dysarthria [8],
language deficits [10] and severe speech impairment [9].
More complex cases carrying mutations and microdele-
tions of FOXP2 have also been described [11–13].
In this paper, we report on a young female who pre-
sents with a severe speech and language disorder and a
de novo chromosomal rearrangement involving chromo-
somes 7 and 11. Given the phenotype of this patient and
the karyotypic profile [14], we hypothesized that she
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may represent an additional FOXP2 case. We used
molecular cytogenetics to map the chromosome
breakpoints and discovered a complex rearrangement
involving an inversion of chromosome 7, followed by
a translocation between the inverted chromosome 7
and chromosome 11 {(46, XX, der(7)inv(7)(p15;q31)
t(7;11)(q21;p12), der(11)t(7;11)(q21;p12)}. The precise
localization of the 7q31 breakpoint was further refined




The patient was born after 42 weeks of gestation to a
27 years and 10 month old female. No complications
were observed during the pregnancy and the delivery
was normal. At birth, the weight was 2.550 kg, the
height 50.5 cm and cephalic perimeter 35 cm. APGAR
evaluation scores were normal. A moderate neonatal de-
pression was observed in the newborn prompting the
administration of intravenous fluids. Further exploration
suggested intrauterine malnutrition, moderate jaundice
without hepato-splenomegaly and vaginal bleeding. The
child had feeding difficulties with frequent vomiting epi-
sodes but motor milestones were normal. Binocular
astigmatism was present, requiring the use of glasses.
An audiometry performed at 11 years and 2 months, re-
vealed 10 % hearing loss in the right ear and a 5.4 %
hearing loss on the left ear.
Language and neurodevelopment
The proband languages are Castilian-Spanish and
Valencian. She first spoke at 12 months of age but
her expressive language was severely delayed and ar-
ticulation imprecise. At 5 years of age, she used only
sequences of two words and her speech production
was unintelligible. Velar stops, alveolar rhotics and
laterals were not produced. Nasal and fricative alveo-
lar articulations were not present after vowels in
consonant clusters. There were frequent substitu-
tions, omissions and miss-timings of single articula-
tions in a sequence. EEG analysis showed normal
activity (63/04) at this age. She has attended speech
therapy sessions since the age of 5. The Illinois Test
of Psycholinguistic Aptitude [15] was administered at
9 years and 6 months of age and the proband was
found to score below typically developed children
(Additional file 1: Table S1). In motor expression the
proband scored three years below expected.
At age 9 years and 11 months, she was diagnosed with
Specific Language Impairment. At age 10 years and
8 months, her total IQ score [16] was in the normal-low
range (88), her verbal IQ was low (74) while her non-
verbal IQ was above the mean for her age (106). Verbal
deficits were particularly prominent in the information
and vocabulary subtests in both languages (Additional
file 1: Figure S1 A, B). A laterality test pointed to left
handedness but right visual preference. The proband
shows empathy to others and socializes with friends,
usually of a younger age. She displays impulsive behavior
but shows explicit attempts to resolve conflict with
others. At the onset of puberty (age 12 years, 11 months),
the proband showed sleep disturbance and symptoms of
Obsessive Compulsive Behavior. Medication was initi-
ated at 13 years and 3 months (a serotonin reuptake
inhibitor), improving sleep patterns and obsessive-
behavior. However, at age 15 years and 1 month, she re-
ported auditory hallucinations. Additional medication
(quetiapine hemifumarate) was started at age 15 years
and 2 months, and the auditory hallucinations seem to
have stopped. The difficulties experienced by the pro-
band led to problems following a normal pace of learn-
ing at school and she has attended a special education
unit since the age of 13 years and 9 months.
None of the patient’s family members have suffered
developmental language disorders from the maternal or
paternal side.
Sequencing of the coding regions of FOXP2
In order to rule out the involvement of FOXP2 by inci-
dental mutation, we sequenced the coding regions of all
FOXP2 transcripts. No splice site or coding variants
were found (data not shown).
Molecular cytogenetic analysis
A complex chromosomal rearrangement in this proband
had been previously suggested by classical cytogenetic
analysis [14]. M-FISH (Fig. 1a) and DAPI banding on
metaphase spreads from peripheral blood lymphocytes
confirmed the presence of a 7 pericentric inversion, and
a 7–11 reciprocal translocation. We therefore hypothe-
sized a rearrangement involving two steps: firstly a
pericentric inversion of chromosome 7 with one break-
point around 7p15 and one around 7q31 (Fig. 1b, α/α’
and β/β’ respectively), which generated a lost inter-
mediate inverted chromosome 7 (Fig. 1b, inv7). This
event was followed by a reciprocal translocation be-
tween the inv7 and the short arm of chromosome 11,
with breakpoints around 7q21 and 11p12 (Fig. 1B, γ/γ’
and δ/δ’ respectively).
Considering that FOXP2 is localized in band 7q31
(114,055,052-114,333,827, hg19) possible disruption of
its locus was probed using five BACs (Table 1) spanning
region 113,695,289-114,374,043 (hg19), on chromosome
7. The BACs mapped correctly to chr7q31 in the par-
ents. In the proband, the five BACs were found to
hybridize to the derivative chromosome 11 short arm
or der(11)t[7q31;11p12], in addition to the normal
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chromosome 7 as expected (Fig. 1c). These results indicate
that although the FOXP2 locus has been translocated to de-
rivative chromosome 11, the locus itself was not directly
disrupted by the breakpoint, which is located distally of
position 114,374,043 (hg19).
To localize the putative breakpoints within each chromo-
some region, we hybridized a series of genomic BAC clones
(Table 1 and Additional file 1: Table S2) on metaphase
spreads from peripheral blood and skin fibroblasts from the
proband, and parents. The hybridization pattern of all BACs
was normal in one copy of the proband’s chromosomes 7
and 11, and in both chromosomes in the parents (data not
shown), confirming that the rearrangement was de novo.
7p21-15 (α/α’ inversion breakpoint)
The location of the 7p inversion breakpoint was defined
by four overlapping BACs (RP11-61 N24, RP11-799 L23,
RP11-97 L4, and RP11-1129E15 - Table 1). In the pro-
band, RP11-61 N24 localized in the derivative 11p,
RP11-799 L23 localized partially on the derivative 11p
and partially on the derivative 7q, RP11-97 L4 localized
partially on the derivative 11p and partially on the de-
rivative 7q and RP11-1129E15 localized in the derivative
7q (Additional file 1: Figure S2). Based on these data,
the breakpoint maps to the region shared by BACs
RP11-799 L23 and 97 L4, chr7:20,954,043-21,001,537
(hg19, 47.5Kb) on 7p21.1-15.3. This region contains a
long non-coding transcript (AC006481.1 or ENSG0000
0232790).
7q31 (β/β’ inversion breakpoint)
Three overlapping BACs (RP11-259A16; RP11-1 N24;
RP11-243D16) located the inversion breakpoint on
chromosome 7q31 (Table 1, Additional file 1: Figure S2).
Fig. 1 a MFISH karyotype from the proband. The arrows point to the chromosome 7–11 translocation. b hypothetical steps involved in the proband’s
rearrangement. Each of the putative breakpoints is identified by Greek letters. Breakpoints in 7p (α/α’) and 7q (β/β’) lead to a pericentric inversion of
chromosome 7 to generate an inv7 intermediate. This was followed by a translocation between the inv7 p (γ/γ’) and 11 p (δ/δ’). c FISH with BACs (green
signals) spanning the FOXP2 locus, on metaphase spreads from the proband. Each panel shows the hybridization signal from a single BAC probe, as
indicated. The chromosomes are counterstained in DAPI, blue. The five BACs map to the normal chromosome 7 (white arrow), and to the derivative
chromosome 11 (red arrow). No signal is found on the derivative chromosome 7 (green arrow). d Chromatogram of PCR mapping of the inversion
breakpoint, with reference genome (GRCh37/hg19) sequences shown atop and breakpoint marked with a black arrow and dotted line. The sequence
preceding the highlighted nucleotide “G” is on 7p21.1 (light green); the sequence following is on 7q31.1 (dark green). Segments in red show the
respective continuing and preceding sequences on 7p21.1 and 7q31.1 in the reference genome
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In the proband, the signal from RP11-259A16 was local-
ized on the derivative 11p only, while that from RP11-
1 N24 was split between the derivative 11p and the long
arm of t(7,11) (henceforth called derivative 7), and the
signal from RP11-243D16 was found on the derivative
7q only. Thus, the 7q breakpoint is likely to be in the re-
gion that is unique to RP11-1 N24, not shared by either
RP11-259A16 or RP11-243D16. This corresponds to
chr7:114,528,369-114,556,605 (hg19, 28Kb). This region
contains no known genes.
7q21.3 (γ/γ’ translocation breakpoint)
The second 7q translocation breakpoint was mapped to
band 7q21.3, using BACs RP11-7B9 and RP11-248I13
(Table 1). RP11-7B9 localized to the derivative 7 short
arm, and RP11-248I13 to the short arm of the derivative
11 (Additional file 1: Figure S2). Thus, the breakpoint
maps in the region between these two BAC probes,
chr7:93,884,065-93,933,453 (hg19, 49Kb) on 7q21.3.
This region contains lincRNAs (large intergenic non
coding RNAs) or TUCPs (transcripts of uncertain cod-
ing potential), TCONS_00013886, TCONS_00014353,
TCONS_00013888.
11p12 (δ/δ’ translocation breakpoint)
Finally, we located the breakpoint on chromosome 11
using three overlapping BACs: RP11-63D14, RP11-81O6
and RP11-99H2 (Table 1). RP11-63D14 was localized on
the derivative 7 short arm, the RP11-81O6 signal was
split between the derivative 7 short arm, and the deriva-
tive 11 short arm, and RP11-99H2 mapped to the de-
rivative 11 short arm (Additional file 1: Figure S2).
Thus, the breakpoint is localized within the region
unique to BAC RP11-81O6, chr11:38,601,145-38,621,5
72 (hg19, 20.4 Kb). This region contains no known
genes, or non coding elements.
In summary, the FISH data support the hypothetical
two-step model. The hybridization pattern of all BAC
probes was identical in peripheral blood cells and fi-
broblasts, implying that the rearrangement is not
present as mosaic in the patient.
FOXP2 is not directly affected: the FISH of five BACs
spanning its locus showed that it moved to the deriva-
tive 11p, while the region distal to the gene remained in
7q (Table 1, Fig. 1c). In conclusion, the only transcripts
potentially split by the translocation or inversion events
were ENSG00000232790 (7p21.1-15.3) and TCONS_00
013886, TCONS_00013887, TCONS_00014353, TCO
NS_00013888 (7q21.3).
Affymetrix Cytoscan HD arrays analysis in the par-
ents and proband identified no obvious loss of mater-
ial in the regions around the predicted breakpoints.
CNV analyses identified only three inherited copy
number variants in the proband, none of which
coincided with the FOXP2 locus (Additional file 1:
Figure S3).
Table 1 Results of FISH on metaphase spreads from the proband
7p breakpoint (α/α’)
BAC Start (hg19) End (hg19) Cytogenetic band Localization in Proband
RP11-61 N24 20,748,162 20,919,479 7p21.1-p15.3 Derivative 11p
RP11-799 L23 20,810,041 21,001,537 7p21.1-p15.3 Split: derivative 7q, derivative 11p
RP11-97 L4 20,954,043 21,104,475 7p15.3 Split: derivative 7q, derivative 11p
7q breakpoint (β/β’)
BAC Start (hg19) End (hg19) Cytogenetic band Localization in Proband
RP11-259A16 114,374,055 114,528,369 7q31.1-31.2 Derivative 11p
RP11-1 N24 114,451,504 114,603,837 7q31.1-31.2 Split: derivative 7q, derivative 11p
RP11-243D16 114,556,605 114,733,501 7q31.1-31.2 Derivative 7q
RP11-259A16 114,374,055 114,528,369 7q31.1-31.2 Derivative 11p
7q Breakpoint (γ/γ’)
BAC Start (hg19) End (hg19) Cytogenetic band Localization in Proband
RP11-7B9 93,714,463 93,884,065 7q21.3 Derivative 7p
RP11-248I13 93,933,453 94,094,489 7q21.3 Derivative 11p
11p breakpoint (δ/δ’)
BAC Start (hg19) End (hg19) Cytogenetic band Localization in Proband
RP11-63D14 38,455,222 38,604,308 11p12 Derivative 7p
RP11-81O6 38,601,145 38,749,858 11p12 Split: derivative 7q, derivative 11p
RP11-99H2 38,621,572 38,794,051 11p12 Derivative 11p
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PCR breakpoint locus analysis
The breakpoints of the inversion event were precisely
mapped by PCR analysis using primers localized in the
7q31 and 7p21.1-15 regions. A nested Sanger sequencing
reaction produced a fragment that contained sequences
mapping to chr7p21.1(−) and chr7q31.1(+), allowing us
to determine the inversion breakpoints to be chr7:
20,969,207 and chr7:114,539,340, respectively (hg19,
Fig. 1d). The chromosome 7q breakpoint position is
205,513 bp from the 3′ end of FOXP2 and 22,868 bp
from the 5′ of MDFIC. The chromosome 7p breakpoint
directly disrupts the lncRNA ENSG00000232790.
Expression analysis
We used Affymetrix gene expression arrays to compare
the expression levels of genes in and around the
mapped breakpoints in the parents, a sibling and the
proband, on RNA extracted from primary skin fibro-
blasts (LIMMA PLIER analysis, Additional file 2: Table S5).
Two of the non-coding transcripts that fell within the pre-
dicted breakpoints had probes included on these ar-
rays (ENSG00000232790 on chromosome 7p21, and
TCONS_00013886 on chromosome 7q21). Neither
showed significant expression differences between the
sister and the proband (P = 0.91 and P = 0.99 respect-
ively). Notably, no significant differences were seen for
the expression level of FOXP2, although the expres-
sion levels of FOXP2 and the non-coding transcripts
were all too low to accurately assess differences be-
tween samples. However, the expression of some of
the genes controlled by FOXP2 was altered in the pro-
band compared to the sibling. For example, EFNB2,
INHBB, NTN4, ROBO2, and SLC14A1 were upregu-
lated > 3 fold in the proband (LIMMA PLIER analysis,
Additional file 2: Table S5). FOXP2 expression was
therefore further analyzed by Taqman assay, using two
probes. Again, expression levels were low and inconsistent
across RNA batches, precluding a meaningful comparison
between the proband, sibling and parents (Additional file 1:
Table S3 and Additional file 1: Table S4).
Discussion
In this paper, we use molecular cytogenetics to localize
the breakpoints in a young female who presents with a
severe speech and language disorder and a de novo
chromosomal rearrangement involving chromosomes 7
and 11. We report a complex rearrangement involving
an inversion of chromosome 7, followed by a transloca-
tion between the inverted chromosome 7 and chromo-
some 11 {(46, XX, der(7)inv(7)(p15;q31)t(7;11)(q21;p12),
der(11)t(7;11)(q21;p12)}. The breakpoint on 7q31 was
found to map 200Kb from the 3′ end of FOXP2 and
22Kb from the 5′ of MDFIC and directly disrupts the
lncRNA ENSG00000232790. The precise location of
the addition breakpoints have yet to be determined but
the critical regions contain no coding transcripts. We
examined the expression levels of genes around each of
the putative breakpoint sites but did not find any evi-
dence for altered gene expression in these regions.
The breakpoint on 7q31 maps 200Kb to the 3′ UTR
of FOXP2, in which several microRNA target sites have
been described. Although the breakpoint is a distance
from this region, it may have disrupted other yet un-
known expression-controlling elements. Interestingly,
we did observe that the expression of some FOXP2 tar-
gets was altered in the proband compared to her sister.
Among them, ROBO2 is involved in thalamocortical
axons development [17] and has been related to autism
and asocial behavior [18], but also to dyslexia and ex-
pressive vocabulary growth in the normal population
[19]. Although this may represent an artefact of the
analyses (e.g., differences due to age or gender effects),
we cannot rule out the possibility that the expression
pattern of FOXP2 has been affected. Further experi-
ments will be required to confirm this hypothesis, but
at least one other similar patient has been previously
described [9] with breakpoints localized 500 kb down-
stream of FOXP2 UTR region.
We did observe direct disruption of a non coding
element at the 7p21.1-15.3 breakpoint, which might ac-
count for the linguistic deficits observed in the proband.
As it is impossible to assess gene expression directly in
the brain, we chose to examine gene expression levels in
primary skin fibroblasts which express several neuronal
specific receptors and enzymes [20]. However, this ap-
proach does assume that gene expression levels can be
generalized across tissues. Although no expression
differences were found in ENSG00000232790 and
TCONS_00013886 between samples, further valid-
ation would be needed to assess the functionality of
these transcripts. Long non-coding RNAs are import-
ant for fine-tuning of gene regulation and brain
development [21]. They have been implicated in neu-
rodevelopmental disorders [22]. Developmental delay
caused by a disruption of a lincRNA as a result of a
translocation has also been observed [23]. These
studies, as well as our own open up new avenues of
research into the potential involvement of non-
coding RNAs in language disorders. Further add-
itional analyses involving alternative routes will be
required to confirm whether the observed genetic
changes or other factors contribute to the language
impairment in this individual.
Conclusions
In conclusion, the exact genetic cause of the language
impairment exhibited by this clinical case remains to be
fully elucidated. Crucially, a better understanding of the
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role played by non-coding sequences in regulating brain
development may help to understand this complex
dysfunction.
Methods
Ethics approval for this research was granted by the Univer-
sity of Oxford [MSD-IDREC-C1-2012-95, SSD/CUREC2/
09-23].
Fluorescence in-situ hybridization
Metaphase spreads were harvested from peripheral
blood or cultured skin fibroblasts using standard tech-
niques [24]. The MFISH was carried out with the
24XCyte kit (Metasystem, Zeiss LTD) according to
manufacturer instructions. Genomic BACs were a kind
gift from Dr Sam Knight, the Sanger Institute, or ob-
tained from Source Bioscience and Invitrogen. Probes
were labelled by incorporating biotin-16 dUTP, digoxin-
11 dUTP, or FITC-16 dUTP (Roche) with the Nick
Translation Kit (Abbot Molecular) following the manu-
facturer instructions. FISH was performed using stand-
ard techniques [25]. Slides were counterstained and
mounted in DAPI/Vectashield (Oncor) and analysed
with an Olympus BX60 microscope for epifluorescence,
equipped with a Sensys CCD camera (Photometrics,
USA), using Genus Cytovision software (Leica).
PCR breakpoint locus analysis
To refine the inversion breakpoint on chromosome
7q31, long-range PCRs were performed using Phire
Hot Start II DNA polymerase (Thermo Scientific) to
amplify fragments covering the breakpoint locations, as
determined by the cytogenetic analysis. Primers were
designed within Primer 3 [26] using a reference genome
(hg19). Both forward and reverse primers were de-
signed so that they would bind to the same strand on
the reference sequence, as following the inversion the
plus and minus strands from both sides of the break-
point are connected (TCATGCAATGTGTCCCCAAA,
GATTTGCTTAACTGCCCTGC). Thus PCR products
would only be generated if the fragment contained the
breakpoint. The exact breakpoint was then mapped
through a nested Sanger sequence reaction, with in-
ternal primers covering the length of the sequence
predicted to be contained in the PCR product (G
ACTATTTCCAGCCTCTTTATCCT). These were the
primers for the product that contained the breakpoint,
and that other primer sequences are available upon
request.
Mutation screen
The coding regions of FOXP2 were amplified with the
primers used by McDermot et al. [11] via PCR with a
1:9 ration of PFU (Thermo Scientific) and BIOTAQ
(Bioline) and 40 ng of DNA from the proband, extracted
from peripheral blood. The fragments containing the
coding regions were sequenced using Sanger sequencing.
Affymetrix SNP arrays for Copy Number Variation (CNV)
analysis
DNA samples (250 ng extracted from lymphocytes)
from the parents and proband were genotyped on Affy-
metrix Cytoscan arrays by AROS Applied Biotechnol-
ogy (www.arosab.com). These arrays include 750,000
SNPs and allow the detection of copy number changes
and chromosome aberrations in addition to genotypic
information. SNP data were analysed by Affymetrix
Chromosome Analysis Suite (ChAS) and each of the re-
gions surrounding the identified breakpoints examined
for loss or duplication of material, which would be rep-
resented by changes in Log2Ratio and allele peaks.
Gene expression analyses
Total RNA was extracted from fibroblast cell lines gen-
erated from skin biopsies from the proband, her sister
and her parents, and was isolated using the Qiagen Mini
RNeasy kit following the manufacturer’s instructions.
RNA integrity was assessed on a BioAnalyzer (Agilent
Technologies). 200 ng RNA from each sample in three
replicates was used to generate labelled sense single
stranded DNA (ssDNA) for hybridization, with the
Ambion WT Expression Kit, the Affymetrix WT Ter-
minal Labelling, and Controls Kit and the Affymetrix
Hybridization, Wash, and Stain Kit as described by the
manufacturer. Sense ssDNA was fragmented and the
distribution of fragment lengths was measured on a
BioAnalyzer. Fragmented ssDNA was then labelled and
hybridized to the Affymetrix GeneChip Human Gene
2.0 ST Array (Affymetrix). Chips were processed on an
Affymetrix GeneChip Fluidics Station 450 and Scanner
3000.
Affymetrix CEL files were RMA normalized in Gene-
Spring GX 12 and differentially expressed genes identified
using Limma, with a Benjamini and Hochberg multiple
testing correction and a p-value cut off of ≤0.05. A fold
change difference of ≥1.5 was used. In order to investigate
if the expression of genes around the putative breakpoint
sites or genes which are known to be targets of FOXP2
would show any significant deviation in the proband from
the family, the expression of these genes was assessed
using LIMMA PLIER. Average expression levels were first
compared across replicates between the proband and her
sister. Genes which had significantly different expression
levels in the proband and her sister were then manually
compared between the parents and the proband.
In addition, Taqman probes were used to specifically
measure the expression levels of FOXP2 transcripts in
fibroblast cells from the proband and her family. 0.5 μg
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of RNA was reverse transcribed using the QuantiTect
Reverse Transcription kit (Qiagen) following the manu-
facturers protocol. Three RNA batches were used. Taq-
Man assays from Applied Biosystems (Life Technologies)
were used to perform duplex qPCRs using the stand-
ard TaqMan protocol [27]. Two FOXP2 probes were
used: Hs01074134_m1 for the detection of tran-
scripts NM_148899.3, NM_148900.3, NM_014491.3,
and NM_001172766.2, and Hs01081804_m1 for the de-
tection of transcripts NM_148898.3 and NM_001172767.2,
both of which were FAM-labeled. Mean expression levels
(across triplicate samples, and RNA batches) were deter-
mined using the ΔΔCT method [28] to compare FOXP2
expression levels between the proband and her family
members. Outliers in the CT readings were removed from
the gene expression analyses. Gene expression levels were
normalized against the endogenous control gene IPO8
(TaqMan probe Hs00183533_m1, primer-limited, VIC-labeled).
Additional files
Additional file 1: Table S1. Proband scores at 9;6 (9 years and 6
months of biological age) for The Illinois Test of Psycholinguistic
Aptitudes. Table S2. All BACs hybridized to patient sample to map
breakpoint location. The BACs localization in the patient is highlighted in
color (e.g., the derivative 11p in blue, and the derivative 7p in yellow).
Table S3. Average CT values across three RNA batches. In parentheses,
SE, standard error. Table S4. Relative expression levels of FOXP2 in all
family members compared to the proband, measured with Taqman
probes. Figure S1. A Typical Scores of the proband aged 10;8. Subtests
where answers were required using language are classified as Verbal.
Subtests where language was not required to provide answers are
marked Manipulative. Typical Scores within 8-12 are normal. B. Typical
Verbal Scores of the proband. Typical Verbal Scores refer to subtests
where answers are required in Castilian-Spanish or Valencian. Typical
Scores within 8-12 values are normal. Figure S2. FISH on metaphase
spreads from the proband. Each panel shows the hybridization signal
(green) from a single BAC probe, as indicated (the library name has been
omitted). The chromosomes are counterstained in DAPI, blue. In each
panel a white arrow identifies the normal chromosome 7 (where
present), a green arrow the derivative 7, a yellow arrow the normal
chromosome 11 (where present), and a red arrow the derivative 11.
Figure S3. CNVs were mapped in the probands and parents using
Affymetrix Cytoscan and copy number changes were called within
Affymetrix Chromosome Analysis Suite (ChAS). Stars represent CNVs. The
green line represents the mother, the red line the father and the blue
line the proband. Three CNVs were found in the proband on
chromosomes 2, 14 and 16, Two were paternally inherited (chromosomes
2 and 16) and the third was present in all three individuals tested.
Additional file 2: Table S5. Fibroblast gene expression levels.
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